Skip to main content
Clinical Trials/JPRN-UMIN000045044
JPRN-UMIN000045044
Completed
未知

A study on the effect of intake of the test food on the transition of body surface temperature -open-label placebo-controlled test- - A study on the effect of intake of the test food on the transition of body surface temperature -open-label placebo-controlled test

IMEQRD Co., Ltd0 sites12 target enrollmentAugust 3, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
IMEQRD Co., Ltd
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 3, 2021
End Date
August 18, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
IMEQRD Co., Ltd

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Those who has been currently visiting a hospital or treated with any drug or herbal remedy for any disease. 2\. On diet / exercise therapy under the guidance of a doctor. 3\. Those who have a current or history of serious illness. 4\. Those who are currently taking drugs, quasi\-drug products, foods, or supplements (except for those who can discontinue taking these materials during the trial period after obtaining informed consent). 5\. Those who have a past and current medical history of drugs or food allergy. 6\. Those who have an excessive smoking habit (over 21 cigarettes/day). 7\. Those who have a habit of excessive drinking alcohol habit (over 60 g/day). 8\. Those who are likely to change lifestyle (meal, sleep, motional activity) during test period. 9\. Those who are going to overseas travel during test period. 10\. Those who are currently pregnant or breastfeeding or those who want to become pregnant during the test period. 11\. Those who are currently participating in another clinical trial or who had participated in another clinical trial conducted within a month prior to the submission of an informed consent document. 12\. Those who were determined by the investigator to be unsuitable for participation in this clinical trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials